| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3238109 | General Hospital Psychiatry | 2009 | 7 Pages |
Abstract
Many expert providers prescribe antidepressants to HIV/HCV-coinfected patients initiating Hepatitis C treatment in the absence of symptoms of depression, despite the lack of data supporting this approach in this population. Research is needed to provide an evidence base to guide the optimal psychiatric management of HIV/HCV-coinfected patients beginning hepatitis C treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Jeffrey J. Ph.D., M.S., Susan M.D.,